Al Saran Khalid, Elsayed Sameh, Sabry Alaa, Hamada Mahmoud
Prince Salman Center for Kidney Diseases, Riyadh, Saudi Arabia.
Saudi J Kidney Dis Transpl. 2011 Nov;22(6):1193-8.
Recent evidence highlights the relationship between metabolic syndrome (MS) and increased risk of cardiovascular (CV) diseases. The overall prevalence of the MS is increased in hemodialysis population. To evaluate the prevalence of the MS and obesity in our hemodialysis (HD) patients, we studied 234 HD patients and 34 patients were excluded from the study due to incomplete data at the time of analysis. For the remaining 200 patients, 92% were below the age of 70 years old, 162 (81%) were hypertensive, 90(45%) were diabetic, 54 (27%) had ischemic heart diseases, and 116 (58%) had MS. The incidence of MS in the male and female patients was 50% and 67%, respectively, with a mean abdominal girth more than 94 cm in males and only 14% of the patients revealed abdominal girth measurement below 80 cm in females. We conclude that there is a high prevalence of obesity and MS in our HD patients. Such patients may be at risk of developing morbidities and may benefit from therapy such as lifestyle changes including weight reduction and increased physical activity.
近期证据突显了代谢综合征（MS）与心血管（CV）疾病风险增加之间的关系。血液透析人群中MS的总体患病率有所上升。为评估我们血液透析（HD）患者中MS和肥胖症的患病率，我们研究了234例HD患者，分析时因数据不完整有34例患者被排除在研究之外。对于其余200例患者，92%年龄在70岁以下，162例（81%）患有高血压，90例（45%）患有糖尿病，54例（27%）患有缺血性心脏病，116例（58%）患有MS。男性和女性患者中MS的发病率分别为50%和67%，男性平均腹围超过94厘米，女性中只有14%的患者腹围测量值低于80厘米。我们得出结论，我们的HD患者中肥胖症和MS的患病率很高。这类患者可能有发生疾病的风险，可能会从诸如减重和增加体育活动等生活方式改变的治疗中获益。
